agnus castus
heel belgium n.v. booiebos 25 b-9031 drongen (belgiË) - agnus castus lm1 t/m lm30 ; d4 t/m d200 ; 6k t/m 50.000k ; 2ch t/m 200ch - , , , , , , , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:14 maart 2002
agnus castus
heel belgium n.v. booiebos 25 b-9031 drongen (belgiË) - agnus castus lm1 t/m lm30 ; d4 t/m d200 ; 6k t/m 50.000k ; 2ch t/m 200ch - , , , , , , , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:14 maart 2002
agnus castus
heel belgium n.v. booiebos 25 b-9031 drongen (belgiË) - agnus castus lm1 t/m lm30 ; d4 t/m d200 ; 6k t/m 50.000k ; 2ch t/m 200ch - , , , , , , , , , , , , , , , , , , , , , , , , , , , , - datum verstrekking handelsvergunning:14 maart 2002
mulimen druppels opl. druppelfl.
heel belgium sa-nv - agnus cactus d3 11,11 g; kalium carbonicum d4 11,11 g; hypericum perforatum d3 11,11 g; gelsemium sempervirens d4 11,11 g; cimicifuga racemosa d4 11,11 g; calcarea carbonica ostrearum d8 11,11 g; ambra grisea d4 11,11 g; sepia officinalis d8 11,11 g - druppels voor oraal gebruik, oplossing - agnus cactus; ambra grisea; calcarea carbonica ostrearum; cimicifuga racemosa; gelsemium sempervirens; hypericum perforatum; sepia officinalis; kalium carbonicum
purevax rcp felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
purevax rcpch felv
boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - immunologicals voor felidae, - cats - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.
donnafyta premens 40 mg filmomh. tabl.
will pharma sa-nv - agnus castus, droog extract 40 mg - filmomhulde tablet - 40 mg - agnus castus, droog extract 40 mg - other gynecologicals
combigan 2 mg/ml + 5 mg/ml, oogdruppels, oplossing
allergan pharmaceuticals ireland castlebar road westport, county mayo (ierland) - brimonidinetartraat 2 mg/ml samenstelling overeenkomend met ; brimonidine 1,3 mg/ml ; timololmaleaat 6,8 mg/ml samenstelling overeenkomend met ; timolol 0-water 5 mg/ml - oogdruppels, oplossing - benzalkoniumchloride ; dinatriumwaterstoffosfaat 7-water (e 339) ; natriumdiwaterstoffosfaat 1-water (e 339) ; natriumhydroxide (e 524) ; water, gezuiverd ; zoutzuur (e 507), - timolol, combinations
combigan 2 mg/ml + 5 mg/ml, oogdruppels, oplossing
euro registratie collectief b.v. - brimonidinetartraat samenstelling overeenkomend met; brimonidine; timololmaleaat samenstelling overeenkomend met; timolol 0-water; - oogdruppels, oplossing - timolol, combinations
combigan 2 mg - 5 mg oogdruppels opl. druppelfl.
abbvie sa-nv - timololmaleaat 6,8 mg/ml - eq. timolol 5 mg/ml; brimonidinetartraat 2 mg/ml - eq. brimonidine 1,3 mg/ml - oogdruppels, oplossing - 2 mg - 5 mg - timololmaleaat 6.8 mg/ml; brimonidinetartraat 2 mg/ml - timolol, combinations